These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 8053664

  • 1. The effect of systemically administered recombinant human nerve growth factor in healthy human subjects.
    Petty BG, Cornblath DR, Adornato BT, Chaudhry V, Flexner C, Wachsman M, Sinicropi D, Burton LE, Peroutka SJ.
    Ann Neurol; 1994 Aug; 36(2):244-6. PubMed ID: 8053664
    [Abstract] [Full Text] [Related]

  • 2. Dose-dependent effects of recombinant human NGF on grafted adult adrenal medullary tissue.
    Förander P, Björklund L, Strömberg I.
    Exp Neurol; 1994 Apr; 126(2):168-77. PubMed ID: 7523175
    [Abstract] [Full Text] [Related]

  • 3. Development of recombinant human nerve growth factor (rhNGF) as a treatment for peripheral neuropathic disease.
    Rogers BC.
    Neurotoxicology; 1996 Apr; 17(3-4):865-70. PubMed ID: 9086510
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB, Dowell JA, Pratt RD.
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [Abstract] [Full Text] [Related]

  • 5. Safety and pharmacokinetics of recombinant factor XIII in healthy volunteers: a randomized, placebo-controlled, double-blind, multi-dose study.
    Visich JE, Zuckerman LA, Butine MD, Gunewardena KA, Wild R, Morton KM, Reynolds TC.
    Thromb Haemost; 2005 Oct; 94(4):802-7. PubMed ID: 16270634
    [Abstract] [Full Text] [Related]

  • 6. Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: comparison with single and multiple daily doses of filgrastim.
    van Der Auwera P, Platzer E, Xu ZX, Schulz R, Feugeas O, Capdeville R, Edwards DJ.
    Am J Hematol; 2001 Apr; 66(4):245-51. PubMed ID: 11279634
    [Abstract] [Full Text] [Related]

  • 7. Safety and pharmacologic activity of a new nitrate ester, ITF 296, after intravenous administration in healthy volunteers.
    Sardina M, Love R, Mizrahi J, Monzani V, Bianchini C.
    J Cardiovasc Pharmacol; 1995 Apr; 26 Suppl 4():S72-9. PubMed ID: 8839230
    [Abstract] [Full Text] [Related]

  • 8. Pharmacodynamics of subcutaneous recombinant human interleukin-10 in healthy volunteers.
    Huhn RD, Radwanski E, Gallo J, Affrime MB, Sabo R, Gonyo G, Monge A, Cutler DL.
    Clin Pharmacol Ther; 1997 Aug; 62(2):171-80. PubMed ID: 9284853
    [Abstract] [Full Text] [Related]

  • 9. Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein Ro 45-2081 (lenercept): a double blind, placebo controlled dose-finding study in rheumatoid arthritis.
    Rau R, Sander O, van Riel P, van de Putte L, Hasler F, Zaug M, Kneer J, van der Auwera P, Stevens RM, Rheumatology Group 791.
    J Rheumatol; 2003 Apr; 30(4):680-90. PubMed ID: 12672184
    [Abstract] [Full Text] [Related]

  • 10. Effect of recombinant human nerve growth factor on cisplatin neurotoxicity in rats.
    Tredici G, Braga M, Nicolini G, Miloso M, Marmiroli P, Schenone A, Nobbio L, Frattola L, Cavaletti G.
    Exp Neurol; 1999 Oct; 159(2):551-8. PubMed ID: 10506527
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: a randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers.
    Lal R, Sukbuntherng J, Luo W, Chen D, Vu A, Tovera J, Cundy KC.
    Clin Ther; 2009 Aug; 31(8):1776-86. PubMed ID: 19808136
    [Abstract] [Full Text] [Related]

  • 12. Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trial.
    Nuki G, Bresnihan B, Bear MB, McCabe D, European Group Of Clinical Investigators.
    Arthritis Rheum; 2002 Nov; 46(11):2838-46. PubMed ID: 12428223
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ, Stevens C, Zhou Y, Yi B, Laethem M, De Smet M, Snyder K, Hilliard D, Tanaka W, Zeng W, Tanen M, Wang AQ, Chen L, Winchell G, Davies MJ, Ramael S, Wagner JA, Herman GA.
    Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
    [Abstract] [Full Text] [Related]

  • 14. Safety and pharmacokinetics of escalating doses of human recombinant nerve growth factor eye drops in a double-masked, randomized clinical trial.
    Ferrari MP, Mantelli F, Sacchetti M, Antonangeli MI, Cattani F, D'Anniballe G, Sinigaglia F, Ruffini PA, Lambiase A.
    BioDrugs; 2014 Jun; 28(3):275-83. PubMed ID: 24327173
    [Abstract] [Full Text] [Related]

  • 15. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A.
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
    O'Farrell AM, van Vliet A, Abou Farha K, Cherrington JM, Campbell DA, Li X, Hanway D, Li J, Guler HP.
    Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550
    [Abstract] [Full Text] [Related]

  • 17. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
    Ramael S, De Smedt F, Toublanc N, Otoul C, Boulanger P, Riethuisen JM, Stockis A.
    Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
    [Abstract] [Full Text] [Related]

  • 18. Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers.
    Wallace M, Schulteis G, Atkinson JH, Wolfson T, Lazzaretto D, Bentley H, Gouaux B, Abramson I.
    Anesthesiology; 2007 Nov; 107(5):785-96. PubMed ID: 18073554
    [Abstract] [Full Text] [Related]

  • 19. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial.
    Cohen S, Hurd E, Cush J, Schiff M, Weinblatt ME, Moreland LW, Kremer J, Bear MB, Rich WJ, McCabe D.
    Arthritis Rheum; 2002 Mar; 46(3):614-24. PubMed ID: 11920396
    [Abstract] [Full Text] [Related]

  • 20. Effect on body weight and safety of RC-1291, a novel, orally available ghrelin mimetic and growth hormone secretagogue: results of a phase I, randomized, placebo-controlled, multiple-dose study in healthy volunteers.
    Garcia JM, Polvino WJ.
    Oncologist; 2007 May; 12(5):594-600. PubMed ID: 17522248
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.